By Dr. Yahia Anane, PhD

Both started life as antiparasitic drugs — ivermectin for humans, fenbendazole for animals. That’s how the world still labels them.

But science has shown that these two compounds go far, far beyond those labels. Both have powerful anti-cancer mechanisms confirmed in hundreds of preclinical studies.

What makes them truly remarkable is not just what they share — it’s how they complete each other. Used together, they cover more cancer biology than either could alone.

⚙️ Where They Create Double Pressure

These are the mechanisms where both drugs hit cancer through the same pathway — meaning the pressure is doubled, not just added.

1. Microtubules — attacked from both directions

Microtubules are the internal “scaffolding” cancer cells use to divide. Without them, no cell can split into two.

• Fenbendazole breaks microtubules down — it destabilizes and depolymerizes them.
• Ivermectin does the opposite — it hyperstabilizes them abnormally, freezing them in place.

Both stop cancer cell division — but from opposite directions. The cancer cell cannot escape either way.

2. mTOR — double metabolic pressure

mTOR is the master growth switch of cancer. Shut it down, and the cancer can’t grow.

• Fenbendazole suppresses mTOR directly.
• Ivermectin suppresses mTOR through a different route — through PAK1 and Akt.

Two different doors to the same room. Both closed simultaneously.

3. Cancer stem cells — the root of recurrence

Cancer stem cells are the small population that survives chemotherapy and rebuilds the tumor later. They are kept alive by the Wnt/β-catenin pathway.

• Ivermectin blocks Wnt/β-catenin — the main survival signal for cancer stem cells.
• Fenbendazole also blocks Wnt/β-catenin — and on top of that, directly targets stem cell populations marked by CD133 and CD44.

This is the most dangerous fraction of any tumor. Both drugs hit it.

Shared mechanisms

Beyond these three, both drugs also share:

• Apoptosis induction — triggering cancer cell death
• Anti-angiogenesis — blocking tumor blood vessel growth
• NF-κB suppression — calming cancer-driving inflammation

Every one of these mechanisms hits harder when both drugs are present at the same time.

🔄 Where They Fill Each Other’s Gaps

This is what makes the combination truly unique. Each drug brings unique tools the other doesn’t have.

What ivermectin brings that fenbendazole cannot:

• PAK1 inhibition — blocks a key oncogenic signaling protein active in over 70% of human cancers
• Strong immune modulation — wakes up T cells and NK cells
• P-glycoprotein inhibition — blocks the pumps cancer cells use to eject chemotherapy

What fenbendazole brings that ivermectin cannot:

• Direct p53 reactivation — restores the body’s most important tumor suppressor
• Ferroptosis — triggers iron-dependent cancer cell death (a completely separate death pathway)
• Strong GLUT1 blockade — cuts off glucose at the entry point of the cell
• G2/M cell cycle arrest — stops cancer cells at a critical division checkpoint

Two drugs. Two completely different gap-fillers. Together, they cover ground that no single drug can.

💊 Dosage and Schedule — How to Use Them Properly

This is where most people go wrong. The drugs are powerful, but only if you use them correctly. Here is the protocol.

Foundation rules (apply to both drugs)

1. Always take with food and healthy fats. Both are fat-soluble. Absorption increases up to 2.6x when taken with fat. Olive oil, avocado, eggs, coconut oil, butter — all work.
2. Split the daily dose in two. Half with one meal, half with another. This keeps blood levels steady and reduces liver stress.
3. Cycle: 5 days on, 2 days off. This gives the liver time to rest, reduces toxicity, and prevents the cancer from adapting.
4. Support the liver. Always add Milk Thistle and TUDCA (500 mg twice daily of each).
5. Monitor liver enzymes every 4 weeks — AST, ALT, GGT, bilirubin.
6. Stay hydrated. At least 2 liters of water per day.
7. Never use alone. These work in synergy with curcumin, vitamin D, omega-3, CBD oil, and the rest of the TMT protocol. They are about 10% of the protocol — not the whole thing.

Ivermectin dosing

The right dose depends on your cancer stage, your liver health, your metabolism, your blood counts, and what other medications you’re taking. Three dose levels are commonly used:

🟢 Low dose — 0.25 to 0.5 mg/kg per day (split in 2)

• For early-stage, non-aggressive cancer, or compromised liver
• Most patients start here to assess tolerance, then adjust upward

🟡 Average dose — around 1 mg/kg per day (split in 2)

• For intermediate-stage cancer with a functional liver
• The most commonly used therapeutic range

🔴 High dose — up to 2 mg/kg per day (split in 2)

• For aggressive, advanced, or treatment-resistant cancer
• Requires a confirmed healthy liver
• Never reach this without gradual escalation and strict monitoring

Research has confirmed ivermectin is well tolerated up to 2 mg/kg with no serious adverse events.

Example: A 70 kg patient at average dose = 70 mg per day, split as 35 mg with breakfast + 35 mg with dinner, 5 days on / 2 days off.

Fenbendazole dosing

250 to 1000 mg, twice per day, with food, 5 days on / 2 days off.

• Start at the lower end (250 mg twice daily = 500 mg/day)
• Increase gradually based on tolerance and response
• Most therapeutic protocols use 500 mg to 2 grams per day total

Important note: Many people online recommend doses far too low (100 mg). At that dose, you won’t get the anti-cancer effect. The published Stanford case series and other reports of complete remissions used therapeutic doses in the gram range, not the parasite-deworming dose.

The 2 days off are also an ideal window for water fasting, which deepens autophagy and lets the body clear damaged cells the drugs have weakened during the 5-day on cycle.

⚠️ Important Cautions

• Liver health is everything. Both drugs are processed by the liver. If your liver enzymes are elevated before starting, fix that first or start at the lowest dose.
• Watch for side effects. Ivermectin at high doses can cause dizziness, fatigue, or blurred vision. Fenbendazole can occasionally raise liver enzymes. Both usually resolve within a few days of pausing.
• Tumor markers may rise initially. This can happen for two reasons: either pre-existing progression catching up, or tumor die-off from active killing. Wait 3–4 months before concluding the protocol isn’t working.
• Drug interactions. Ivermectin is metabolized by CYP3A4 — meaning many medications can change its blood levels. Check every medication you’re on.
• These drugs work with anticoagulants. No problem combining them with blood thinners.
• Quality matters. Buy from reliable sources. Many cheap generics are fake or under-dosed.

🔥 The Bottom Line

Ivermectin and fenbendazole are not interchangeable. They are complementary.

• Double pressure where they overlap — microtubules, mTOR, cancer stem cells, apoptosis, angiogenesis, inflammation
• Complete coverage where they differ — PAK1, immunity, P-glycoprotein on the ivermectin side; p53, ferroptosis, GLUT1, cell cycle arrest on the fenbendazole side

Two old drugs. Decades of safety data. Hundreds of preclinical studies. Together they cover more cancer biology than any single drug — and far more than either drug alone.

But remember: they are only about 10% of the full protocol. The diet, fasting, supplements, liver support, monitoring, and lifestyle pieces are the other 90%. Don’t cherry-pick. Use them inside a complete Targeted Metabolic Therapy framework, and they become some of the most powerful tools you have.

This article is for education only and does not replace medical advice. Always work with a qualified healthcare professional experienced in metabolic oncology — especially if you are on chemotherapy, anticoagulants, or other medications.

Dr. Yahia Anane, PhD — drananeyahia.com